Chemistry: natural resins or derivatives; peptides or proteins; – Proteins – i.e. – more than 100 amino acid residues – Lymphokines – e.g. – interferons – interlukins – etc.
Reexamination Certificate
2006-06-20
2006-06-20
Woitach, Joseph (Department: 1632)
Chemistry: natural resins or derivatives; peptides or proteins;
Proteins, i.e., more than 100 amino acid residues
Lymphokines, e.g., interferons, interlukins, etc.
C424S130100, C424S178100, C424S184100, C530S387100, C530S402000
Reexamination Certificate
active
07064185
ABSTRACT:
Polynucleotides encoding mammalian ECM signalling molecules affecting the cell adhesion, migration, and proliferation activities characterizing such complex biological processes as angiogenesis. chondrogenesis, and oncogenesis, are provided. The polynucleotide compositions include DNAs and RNAs comprising part, or all, of an ECM signalling molecule coding sequence, or biological equivalents. Polypeptide compositions are also provided. The polypeptide compositions comprise mammalian ECM signalling molecules, peptide fragments, inhibitory peptides capable of interacting with receptors for ECM signalling molecules, and antibody products recognizing Cyr61. Also provided are methods for producing mammalian ECM signalling molecules. Further provided are methods for using mammalian ECM signalling molecules to screen for, and/or modulate, disorders associated with angiogenesis, chondrogenesis, and oncogenesis: ex vivo methods for using mammalian ECM signalling molecules to prepare blood products are also provided.
REFERENCES:
patent: 4554101 (1985-11-01), Hopp
patent: 5408040 (1995-04-01), Grotendorst et al.
patent: 5565332 (1996-10-01), Hoogenboom et al.
patent: 5945300 (1999-08-01), Li et al.
patent: 6008022 (1999-12-01), Su et al.
patent: 6149916 (2000-11-01), Grotendorst et al.
patent: 6150101 (2000-11-01), Grotendorst et al.
patent: 2329697 (1997-10-01), None
patent: 733382 (2001-05-01), None
patent: 2248549N (1997-09-01), None
patent: 0888452 (1999-01-01), None
patent: 0 495 674 (1992-07-01), None
patent: 2000506732 (2000-06-01), None
patent: WO 96/01896 (1996-01-01), None
patent: WO 97/33995 (1997-09-01), None
patent: WO 9733995 (1997-09-01), None
Jay et al., Oncogene 14:1753-1757, 1997.
Kireeva et al. Exp Cel Research 233:63-77, 1997.
Latinkic et al. NAR 19(12):3261-3267, 1991.
O'Brian et al. Molecular and Cellualar Biology 10(7):3569-77, Jul. 1990.
G.D. Phillips et al., Natl.Library of Medicine, “Vascular endothelial growth factor(rhVEGF165) stimulates direct angiogenesis in the rabbit cornea,” in vivo Nov.-Dec. 1994,8(6):abstract.
T.Kanoh et al., Natl. Library of Medicine, “Suppression of in vivo tumor-induced angiogenesis by the protein-bound polysaccharide PSK,” in vivo Mar.-Apr. 1994, 8(2):abstract.
G.D. Phillips et al., Natl.Library of Medicine, “Platelet derived wound healing factors (PDWHF) accelerate and augment wound healing angiogenesis in the rat,” in vivo Mar.-Apr. 1994,8(2):abstract.
D.S.Grant et al., Annals New York Academy of Sciences,“ Role of Basement Membranes in Vascular Development,” (1990),588:61-72.
A.E.Canfield et al., Journal of Cell science,“Evidence that tenascin and thrombospondin-1 modulate sprouting of endothelial cells,” Feb. 1995, 108,pp. 797-809.
M.L. Kireeva et al., Molecular and Cellular Biology, “Cyr61, a Product of a growth Factor-Inducible immediate-early gene, promotes cell proliferation, migration, and adhesion,” Apr. 1996, vol. 16, No. 4, pp. 1326-1334.
A.M. Babic et al., Proc. Natl.Acad.Sci . USA,“Cyr61, a product of a growth factor-inducible immediate early gene, promotes agiogenesis and tumor growth,” May 1998, vol. 95, pp. 6355-6360.
J.U. Bowie et al., Science, “Deciphering the message in protein sequences:tolerance to amino acid substitutions,” Mar. 1990, vol. 247, pp. 1306-1310.
J.T. Ngo et al., Protein Folding Problem and Teriay Structure Prediction, “Computational complexity, protein structure prediction, and the levinthal paradox, ”14:491-495.
J.A. Parsons, Natl.Institute for Medical Research, “Peptide Hormones,” Jun. 1976, pp. 5-7.
Adra, C.N. et al., “Cloning and expression of the mouse pgk-1 gene and the neucleotide sequence of its promoter,” Gene, 60:65-74 (1987).
Ahrens, P.B. et al., “Stage-Related Capacity for Limb Chondrogenesis in Cell Culture,” Developmental Biology, 60:69-82 (1977).
Bradham, D.M. et al., “Connective Tissue Growth Factor: a Cysteine-rich Mitogen Secreted by Human Vascular Endothelial Cells Is Related to the SRC-induced Immediate Early Gene Product CEF-10,” Journal Cellular Biology, 114(6):1285-1294 (Sep., 1991).
Fajardo, L.F. et al., “Methods in Laboratory Investigation: The Disc Angiogenesis System,” Laboratory Investigation, 58(6):718-724 (1988).
Greenberger, J.S. et al., “Demonstration of permanent factor-dependent multipotential (erythroid
eutrophil/basophol) hematopoietic progenitor cell lines,” Proc. Natl. Acad. Sci. (USA), 80:2931-2935 (May,1983).
Hartzell, S. et al., “A Growth Factor-Responsive Gene of Murine BALB/c 3T3 Cells Encodes a Protein Homologous to Human Tissue Factor,” Molecular and Cellular Biology, 9(6):2567-2573 (Jun., 1989).
Joliot, V. et al., “Proviral Rearrangements and Overexpression of a New Cellular Gene (nov) in Myeloblastosis-Associated Virus Type 1-Induced Nephroblastomas,” Molecular and Cellular Biology, 12(1):10-21 (Jan., 1992).
Latinkic, B.V. et al., “Promoter function and structure of the growth factor-inducible immediate early gene cyr61,” Nucleic Acids Research, 19(12):3261-3267 (1991).
Lau, L.F. et al., “Identification of a set of genes expressed during the G0-G1 transition of cultured mouse cells,” EMBO Journal, 4(12):3145-3151 (1985).
Lau, L.F. “Growth factors and growth control,” Current Opinion in Cell Biology, 2:280-284 (1990).
Lau, L.F. et al., “Expression of a set of growth-related immediate early genes in BALB/c 3T3 cells: Coordinate regulation with c-fos or c-myc,” Proc. Natl. Acad. Sci. (USA), 84:1182-1186 (Mar., 1987).
Lau, L.F. et al., “Genes induced by serum growth factors,” in Molecular Aspects of Cellular Regulation, vol. 6: The hormonal control regulation of gene transcription, Chapter 13, Cohen, P. et al., (eds.), Elservier Science Publishers B.V., Amersterdam, pp. 257-293 (1991).
O'Brien, T.P. et al., “Expression of cyr61, a Growth Factor-Inducible Immediate-Early Gene,” Molecular and Cellular Biology, 10(7):3569-3577 (Jul., 1990).
O'Brien, T.P. et al., “Expression of the Growth Factor-inducible Immediate Early Gene cyr61 Correlates with Chondrogenesis during Mouse Embryonic Development,” Cell Growth & Differentiation, 3:645-654 (Sep., 1992).
Ryseck, R-P. et al., “Structure, Mapping, and Expression of fisp-12, a Growth Factor-inducible Gene Encoding a Secreted Cysteine-rich Protein,” Cell Growth and Differentiation, 2:225-233 (May, 1991).
Spooncer, E. et al., “Continuous in vitro generation of multipotential stem cell clones form src-infected cultures,” Nature, 310:288-230 (Jul., 1984).
Tolsma, S.S. et al., “Peptides Derived from Two Separated Domains of the Matrix Protein Thrombospondin-1 Have Anti-Angiogenic Activity,” Journal of Cell Biology, 122(2):497-511 (Jul., 1993).
Yang, G.P. et al., “Cyr61, Product of a Growth Factor-inducible Immediate Early Gene, Is Associated with Extracellular Matrix and the Cell Surface,” Cell Growth and Differentiation, 2:351-357 (Jul., 1991).
Yang, G.P., “Biochemical and Functional Analysis of Cyr61, The Product of a Growth Factor-Inducible Immediate Early Gene,” Ph.D. Thesis, University of Illinois at Chicago, Chicago, Illinois (1993).
Iwamoto et al., Advances in Experimental Medicine and Biology, 324:141-149 (1992).
Yang, G.P. Dissertaion Abstracts International, 54(8):DA9335171, February, (1994).
O'Brien et al. Cell Growth and Differentiation 3:645-354, (1992).
Bork, P. FEBS letters 327(2):125-130, July, (1993).
Lin et al. Cancer Research 53:2950-2953, July, (1993).
Felch et al., Regional Immunology 4:363-370, (1992).
Mackinnon et al., Invasion Metastasis 12:241-252 (1992).
Wallukar, G. et al. Z. Kardiol., 81:Suppl. 4, 79-83 (1992).
Hoermann, et al. Acta Endocrinologica 111:487-493 (1986).
Jedsadayanmata et al. “Activation-dependent adhision of human platelets to Cyr 61 and Fisp12/Mouse Connective Tis
Clough David W.
Howrey LLP
Munin Corporation
Woitach Joseph
LandOfFree
Antibody for human Cyr61 does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Antibody for human Cyr61, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Antibody for human Cyr61 will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3623968